MARKSANS

Marksans Pharma Share Price Marksans Pharma

₹157.95
-0.7 (-0.44%)
24 February, 2024 14:23 BSE: 524404 NSE: MARKSANSISIN: INE750C01026

Start SIP in Marksans Pharma

Start SIP

Marksans Pharma Performance

Day Range

  • Low 157
  • High 164
₹ 157

52 Week Range

  • Low 64
  • High 179
₹ 157
  • Open Price162
  • Previous Close159
  • Volume930741

Marksans Pharma Share Price

  • Over 1 Month 5.19%
  • Over 3 Month 9.16%
  • Over 6 Month 39.22%
  • Over 1 Year 129.25%

Marksans Pharma Key Statistics

P/E Ratio 22.6
PEG Ratio 0.5
Market Cap Cr 7,158
Price to Book Ratio 4.1
EPS 2.3
Dividend 0.3
Relative Strength Index 51.78
Money Flow Index 67.44
MACD Signal 0.5
Average True Range 7.28
Marksans Pharma Financials
IndicatorDec 2023Sep 2023Jun 2023Mar 2023
Oper Rev Qtr Cr 241205182153
Operating Expenses Qtr Cr 199167155130
Operating Profit Qtr Cr 42372723
Depreciation Qtr Cr 8854
Interest Qtr Cr 0001
Tax Qtr Cr 913105
Net Profit Qtr Cr 25314418
IndicatorMar 2023
Total Revenue Annual Cr 716
Operating Expenses Annual Cr 563
Operating Profit Annual in Cr 92
Depreciation Cr 17
Interest Annual Cr 4
Tax Annual Cr 29
Net Profit Annual Cr 103
IndicatorMar 2023
Cash from Operating Activity Annual Cr 52
Cash from Investing Activity Annual Cr -195
Cash from Financing Annual Activity Cr 210
Net Cash Flow Annual Cr 67
IndicatorMar 2023
Total ShareHolders Funds Annual Cr 1,111
Fixed Assets Annual Cr 148
Total Non Current Assets Annual Cr 431
Total Current Assets Annual Cr 914
Total Assets Annual Cr 1,345
IndicatorMar 2023
Book Value Per Share Annual Rs 25
ROE Annual % 9
ROCE Annual % 12
Total Debt to Total Equity Annual -
EBDIT Annual Margin % 23
IndicatorDec 2023Sep 2023Jun 2023Mar 2023
Oper Rev Qtr Cr 586531500486
Operating Expenses Qtr Cr 453417398376
Operating Profit Qtr Cr 133114102110
Depreciation Qtr Cr 22181414
Interest Qtr Cr 3222
Tax Qtr Cr 30302621
Net Profit Qtr Cr 83846982
IndicatorMar 2023
Total Revenue Annual Cr 1,911
Operating Expenses Annual Cr 1,513
Operating Profit Annual in Cr 339
Depreciation Cr 52
Interest Annual Cr 9
Tax Annual Cr 72
Net Profit Annual Cr 266
IndicatorMar 2023
Cash from Operating Activity Annual Cr 237
Cash from Investing Activity Annual Cr -259
Cash from Financing Annual Activity Cr 198
Net Cash Flow Annual Cr 176
IndicatorMar 2023
Total ShareHolders Funds Annual Cr 1,745
Fixed Assets Annual Cr 458
Total Non Current Assets Annual Cr 515
Total Current Assets Annual Cr 1,675
Total Assets Annual Cr 2,190
IndicatorMar 2023
Book Value Per Share Annual Rs 39
ROE Annual % 15
ROCE Annual % 19
Total Debt to Total Equity Annual -
EBDIT Annual Margin % 22

Marksans Pharma Technicals

EMA & SMA

Current Price
₹157.95
-0.7 (-0.44%)
pointer
  • Bullish Moving Average
  • ___
  • 11
  • Bearish Moving Average
  • ___
  • 5
  • 20 Day
  • ₹156.86
  • 50 Day
  • ₹154.10
  • 100 Day
  • ₹144.24
  • 200 Day
  • ₹125.72
  • 20 Day
  • ₹154.72
  • 50 Day
  • ₹158.14
  • 100 Day
  • ₹143.17
  • 200 Day
  • ₹121.11

Marksans Pharma Resistance and Support

PIVOT
₹159.54
Resistance
First Resistance 161.97
Second Resistance 165.98
Third Resistance 168.42
RSI 51.78
MFI 67.44
MACD Single Line 0.50
MACD 1.08
Support
First Resistance 155.52
Second Resistance 153.08
Third Resistance 149.07

Marksans Pharma Delivery and Volume

Period NSE + BSE Volume Avg NSE + BSE Delivery Volume Avg NSE + BSE Delivery Volume %
Day 1,064,653 45,833,312 43.05
Week 1,349,005 59,126,898 43.83
1 Month 1,779,011 86,797,949 48.79
6 Month 2,736,409 111,809,664 40.86

Marksans Pharma Result Highlights

Marksans Pharma Synopsis

NSE-Medical-Diversified

Marksans Pharma is involved in the business activities of Manufacture of pharmaceuticals, medicinal chemical and botanical products. Company’s Total Operating Revenue is Rs. 655.20 Cr. and Equity Capital is Rs. 45.32 Cr. for the Year ended 31/03/2023. Marksans Pharma Ltd. is a Public Limited Listed company incorporated on 16/04/1992 and has its registered office in the State of Maharashtra, India. Company’s Corporate Identification Number(CIN) is L24110MH1992PLC066364 and registration number is 066364.
Market Cap 7,158
Sales 781
Shares in Float 25.38
No of funds 101
Yield 0.32
Book Value 6.44
U/D Vol ratio 1.2
LTDebt / Equity
Alpha 0.24
Beta 1.06

Marksans Pharma

Owner NameDec-23Sep-23Jun-23Mar-23
Promoters 43.85%43.85%43.85%43.85%
Mutual Funds 3.82%3.15%2.79%0.86%
Foreign Portfolio Investors 4.67%4.19%4.02%4.23%
Financial Institutions/ Banks
Individual Investors 30.8%32.12%32.37%34.42%
Others 16.86%16.69%16.97%16.64%

Marksans Pharma Management

Name Designation
Mr. Mark Saldanha Chairman & Managing Director
Mrs. Sandra Saldanha Whole Time Director
Mr. Seetharama R Buddharaju Independent Director
Mr. Abhinna Sundar Mohanty Independent Director
Mr. Digant Mahesh Parikh Independent Director
Mr. Varddhman V Jain Whole Time Director
Mrs. Shailaja Vardhan Independent Director
Dr. Sunny Sharma Non Executive Director

Marksans Pharma Forecast

Price Estimates

2,000(9.8%)
1,758(-3.5%)
1,590(-12.7%)

Other Analyst Rating

Marksans Pharma Corporate Action

Date Purpose Remarks
2024-02-13 Quarterly Results
2023-11-09 Quarterly Results
2023-08-11 Quarterly Results
2023-05-30 Audited Results & Final Dividend
2023-02-13 Quarterly Results
Date Purpose Remarks
2023-06-07 FINAL Rs.0.50 per share(50%)Final Dividend

Marksans Pharma FAQs

What is Share Price of Marksans Pharma ?

Marksans Pharma share price is ₹157 As on 24 February, 2024 | 14:09

What is the Market Cap of Marksans Pharma ?

The Market Cap of Marksans Pharma is ₹7157.7 Cr As on 24 February, 2024 | 14:09

What is the P/E ratio of Marksans Pharma ?

The P/E ratio of Marksans Pharma is 22.6 As on 24 February, 2024 | 14:09

What is the PB ratio of Marksans Pharma ?

The PB ratio of Marksans Pharma is 4.1 As on 24 February, 2024 | 14:09

Q2FY23